As previously announced, Michael assumed the role on July 1.
You may also like
Pharma Pulse 7/8/24: New AI Tech Spurs Excitement/Concerns Among Private-Credit Managers, Future Perspectives on Atopic Dermatitis Treatment & more
FDA Grants Fast Track Designation to Inozyme Pharma’s INZ-701, a Treatment for Patients with ABCC6 Deficiency
Carvykti Demonstrates Clinically Meaningful Improvement in Patients with Relapsed or Lenalidomide-Refractory Multiple Myeloma After One Line of Prior Therapy
PrimeRx Launches Digital Platform for Pharmacy Drug Ordering
Pharma Pulse 7/3/24: What to Know About New and Future ALZ Drugs, Bridging the Gap Between Innovation and Implementation & more
Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more
Leave a Reply